SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT AMENDMENT # 1Series B Convertible Preferred Stock Purchase Agreement • December 2nd, 2016 • Oncologix Tech Inc. • Surgical & medical instruments & apparatus • Louisiana
This Series B CONVERTIBLE Preferred Stock Purchase Agreement (the “Agreement”) Amendment # 1, is made and entered into as of November16, 2016, by and among Oncologix Tech, Inc., a Nevada Corporation (the “Company”), and Diversified Innovative Marketing Enterprise Ltd., a Georgia Corporation, “Purchaser”).
LEWIS FAMILY GROUP FUND LP c/o The Schwarz Firm PLLCSecond Modification Agreement • December 2nd, 2016 • Oncologix Tech Inc. • Surgical & medical instruments & apparatus
By letter agreement dated September 21, 2016 (the “First Modification Agreement”), the Lewis Family Group Fund LP (the “Lender”), Oncologix Tech, Inc., and its subsidiaries, Amian Angels, Inc. and Esteemcare Inc. (the “Borrower”), agreed to a 30-day extension of the Maturity Date of September 26, 2015 for the timely loan payoff of the May 26, 2016 Secured Convertible Promissory Note (‘Note II”) in the principal amount of $140,000.00, plus applicable interest, by the Borrower to the Lender on October 26, 2016. Borrower has defaulted on October 26, 2016.
